Isoxsuprine%252525252525252525252525252525252525252520hydrochloride

# Isoxsuprine hydrochloride ## Overview Isoxsuprine hydrochloride is a vasodilator. Its exact mechanism of action in peripheral vascular disease is not fully understood but is thought to involve direct relaxation of vascular smooth muscle. ## Primary Indications * Peripheral vascular disease (PVD) to improve blood flow to the extremities. * Historically used for premature labor, but this indication is no longer recommended due to safety concerns and lack of efficacy. ## Adult Dosing * **Peripheral Vascular Disease:** 10 mg to 20 mg orally three to four times daily. * **Maximum Dose:** Typically not to exceed 80 mg per day. Dosing may be adjusted based on patient response and tolerance, often following specific institutional protocols for PVD management. ## Pediatric Dosing There is no established pediatric dosing for isoxsuprine hydrochloride. Its use in pediatric populations is generally not recommended. ## Dose Adjustments * **Renal Impairment:** No specific dose adjustments are established. Caution is advised in patients with severe renal impairment due to potential accumulation. * **Hepatic Impairment:** No specific dose adjustments are established. Caution is advised in patients with hepatic impairment. ## Contraindications * Hypersensitivity to isoxsuprine hydrochloride. * Use in patients with recent arterial bleeding or hemorrhage. * Use in patients with cardiac arrhythmias. ## Adverse Effects * **Common:** Nausea, vomiting, dizziness, headache, flushing, weakness, gastric distress, hypotension. * **Less Common:** Palpitations, rash, drowsiness, nervousness. ## Key Drug Interactions * **Antihypertensives:** Isoxsuprine may potentiate the effects of antihypertensive medications, leading to excessive hypotension. Monitor blood pressure closely. * **Other Vasodilators:** Concurrent use may lead to additive hypotensive effects. ## Monitoring * Blood pressure and heart rate. * Signs and symptoms of peripheral vascular disease improvement (e.g., increased walking distance, decreased claudication). * Adverse effects. ## Clinical Pearls * Isoxsuprine is generally not considered a first-line agent for PVD due to limited evidence of significant clinical benefit compared to lifestyle modifications and other pharmacological options. * Patients should be advised to avoid activities requiring alertness until they have gained experience with the medication, as it can cause dizziness or drowsiness. * Efficacy in PVD can be variable and is often assessed by symptomatic improvement. *** *Disclaimer: This information is intended for healthcare professionals and is not a substitute for professional medical advice. Always consult the most current prescribing information and relevant clinical guidelines before making any treatment decisions. Drug information can change rapidly, and this summary may not reflect the latest updates.*